Hendrik Nogai
Chief Tech/Sci/R&D Officer at RYVU THERAPEUTICS S.A.
Profile
Dr. Hendrik Nogai, MD, is a Chief Medical Officer at Ryvu Therapeutics SA. Dr. Nogai was previously employed as a Vice President by Bayer Pharmaceuticals /Switzerland/.
He received his doctorate degree from Ludwig-Maximilians-Universität München, a doctorate degree from Charité - Universitätsmedizin Berlin and a doctorate degree from Harvard Medical School.
Hendrik Nogai active positions
| Companies | Position | Start |
|---|---|---|
| RYVU THERAPEUTICS S.A. | Chief Tech/Sci/R&D Officer | 2022-01-31 |
Former positions of Hendrik Nogai
| Companies | Position | End |
|---|---|---|
| Bayer Pharmaceuticals /Switzerland/ | Corporate Officer/Principal | 2021-12-31 |
Training of Hendrik Nogai
| Ludwig-Maximilians-Universität München | Doctorate Degree |
| Charité - Universitätsmedizin Berlin | Doctorate Degree |
| Harvard Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| RYVU THERAPEUTICS S.A. | Health Technology |
| Private companies | 1 |
|---|---|
| Bayer Pharmaceuticals /Switzerland/ |
- Stock Market
- Insiders
- Hendrik Nogai
